BIB
Ultra Nasdaq Biotechnology
Investment Objective
ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.
Documents & Downloads
You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)
Performance
Daily Return during Q3 2024
Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.
Total Return
Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
---|---|---|---|---|---|---|---|---|---|---|
BIB Market Price | 6.12% | 3.45% | 4.41% | 4.41% | 14.59% | -15.42% | 2.84% | 2.54% | 15.70% | 04/07/2010 |
BIB NAV | 6.17% | 3.43% | 4.28% | 4.28% | 14.66% | -15.37% | 2.83% | 2.53% | 15.70% | 04/07/2010 |
Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
---|---|---|---|---|---|---|---|---|---|---|
BIB Market Price | 6.12% | 3.45% | 4.41% | 4.41% | 14.59% | -15.42% | 2.84% | 2.54% | 15.70% | 04/07/2010 |
BIB NAV | 6.17% | 3.43% | 4.28% | 4.28% | 14.66% | -15.37% | 2.83% | 2.53% | 15.70% | 04/07/2010 |
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.
About the Fund
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Gross Expense Ratio 1.15%
- Net Expense Ratio 0.95%
- NAV Calculation Time 4:00 p.m. ET
Price
as of 7/26/2024- NAV $68.27
- NAV Change $+0.70
- Market Price $68.41
- Market Price Change $+0.94
- Trading Volume (M) 15,305
- 30-Day Median Bid Ask Spread 0.00%
- View Premium / Discount
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Expense Ratio 0.95%
- Gross Expense Ratio 1.15%
- NAV Calculation Time 4:00 p.m. ET
Price
as of 7/26/2024- NAV $68.27
- NAV Change $+0.70
- Market Price $68.41
- Market Price Change $+0.94
- Trading Volume (M) 15,305
- 30-Day Median Bid Ask Spread 0.00%
- View Premium / Discount
The expense ratio above has a contractual waiver ending 9/30/24.
Exposures
Index as of 6/28/2024
Holdings
as of 7/26/2024
Exposure Weight | Ticker | Description | Exposure Value (Notional + GL) |
Market Value | Shares/Contracts | SEDOL Number |
---|---|---|---|---|---|---|
52.42% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 51,893,107 | -- | 10,598 | -- |
36.94% | -- | NASDAQ BIO INDEX SWAP BNP | 36,567,062 | -- | 7,468 | -- |
24.67% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 24,418,846 | -- | 4,987 | -- |
7.49% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 7,413,301 | -- | 1,514 | -- |
6.53% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 6,468,277 | -- | 1,321 | -- |
5.55% | GILD | GILEAD SCIENCES INC | -- | $5,490,350.94 | 71,294 | 2369174 |
5.09% | REGN | REGENERON PHARMACEUTICALS | -- | $5,042,595.25 | 4,675 | 2730190 |
5.07% | AMGN | AMGEN INC | -- | $5,016,387.85 | 14,981 | 2023607 |
5.03% | VRTX | VERTEX PHARMACEUTICALS INC | -- | $4,983,801.38 | 10,063 | 2931034 |
4.38% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 4,338,299 | -- | 886 | -- |
3.38% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC | 3,344,310 | -- | 683 | -- |
2.88% | MRNA | MODERNA INC | -- | $2,847,971.53 | 23,323 | BGSXTS3 |
2.32% | AZN | ASTRAZENECA PLC-SPONS ADR | -- | $2,294,209.32 | 29,364 | 2989044 |
1.92% | BIIB | BIOGEN INC | -- | $1,897,995.96 | 8,988 | 2455965 |
1.85% | ALNY | ALNYLAM PHARMACEUTICALS INC | -- | $1,833,865.56 | 7,809 | B00FWN1 |
1.20% | ILMN | ILLUMINA INC | -- | $1,184,308.62 | 9,834 | 2613990 |
1.00% | BMRN | BIOMARIN PHARMACEUTICAL INC | -- | $991,563.98 | 11,722 | 2437071 |
0.99% | ARGX | ARGENX SE - ADR | -- | $978,041.88 | 1,978 | BDVLM39 |
0.96% | INCY | INCYTE CORP | -- | $951,963.75 | 13,875 | 2471950 |
0.94% | UTHR | UNITED THERAPEUTICS CORP | -- | $926,384.58 | 2,739 | 2430412 |
0.92% | NBIX | NEUROCRINE BIOSCIENCES INC | -- | $911,921.60 | 6,212 | 2623911 |
0.92% | SNY | SANOFI-ADR | -- | $911,236.00 | 17,390 | 2964557 |
0.90% | VTRS | VIATRIS INC | -- | $887,952.48 | 73,506 | BMWS3X9 |
0.85% | SRPT | SAREPTA THERAPEUTICS INC | -- | $840,774.96 | 5,829 | B8DPDT7 |
0.81% | RPRX | ROYALTY PHARMA PLC- CL A | -- | $801,715.13 | 27,847 | BMVP7Y0 |
0.75% | INSM | INSMED INC | -- | $741,896.62 | 9,953 | 2614487 |
0.74% | MEDP | MEDPACE HOLDINGS INC | -- | $729,752.11 | 1,913 | BDCBC61 |
0.57% | PCVX | VAXCYTE INC | -- | $564,563.85 | 6,717 | BKPVGH6 |
0.53% | ITCI | INTRA-CELLULAR THERAPIES INC | -- | $523,982.02 | 6,518 | BHCB0P4 |
0.53% | BNTX | BIONTECH SE-ADR | -- | $520,194.82 | 6,053 | BK6H543 |
0.51% | SMMT | SUMMIT THERAPEUTICS INC | -- | $500,530.80 | 43,336 | BMTVQS7 |
0.50% | ROIV | ROIVANT SCIENCES LTD | -- | $492,534.00 | 45,605 | BMW4NZ9 |
0.48% | ASND | ASCENDIS PHARMA A/S - ADR | -- | $478,290.00 | 3,576 | BV9G6B8 |
0.48% | RVMD | REVOLUTION MEDICINES INC | -- | $472,991.40 | 10,185 | BL71K91 |
0.47% | IONS | IONIS PHARMACEUTICALS INC | -- | $463,615.95 | 9,011 | BDJ0LS6 |
0.45% | HALO | HALOZYME THERAPEUTICS INC | -- | $442,080.26 | 7,862 | 2975098 |
0.44% | JAZZ | JAZZ PHARMACEUTICALS PLC | -- | $434,230.44 | 3,892 | B4Q5ZN4 |
0.44% | BPMC | BLUEPRINT MEDICINES CORP | -- | $433,726.54 | 3,866 | BWY52P3 |
0.43% | BGNE | BEIGENE LTD-ADR | -- | $428,943.06 | 2,639 | BYYWPW6 |
0.43% | CYTK | CYTOKINETICS INC | -- | $422,545.51 | 7,079 | BBBSBJ5 |
0.42% | EXEL | EXELIXIS INC | -- | $420,622.37 | 17,983 | 2576941 |
0.38% | KRYS | KRYSTAL BIOTECH INC | -- | $376,682.58 | 1,763 | BD6JX35 |
0.38% | MDGL | MADRIGAL PHARMACEUTICALS INC | -- | $374,388.84 | 1,316 | BD59BS7 |
0.32% | BBIO | BRIDGEBIO PHARMA INC | -- | $312,481.60 | 11,552 | BK1KWG8 |
0.31% | CRSP | CRISPR THERAPEUTICS AG | -- | $303,616.64 | 5,242 | BDHF4K6 |
0.30% | NUVL | NUVALENT INC-A | -- | $297,876.50 | 3,650 | BMVBZD3 |
0.30% | APLS | APELLIS PHARMACEUTICALS INC | -- | $297,807.00 | 7,492 | BYTQ6X1 |
0.29% | ALKS | ALKERMES PLC | -- | $291,262.36 | 10,447 | B3P6D26 |
0.29% | LEGN | LEGEND BIOTECH CORP-ADR | -- | $285,484.23 | 5,043 | BMX9K07 |
0.29% | RNA | AVIDITY BIOSCIENCES INC | -- | $284,218.56 | 5,904 | BMWHPY1 |
0.27% | DYN | DYNE THERAPEUTICS INC | -- | $269,495.56 | 6,052 | BN15WD1 |
0.27% | CRNX | CRINETICS PHARMACEUTICALS IN | -- | $264,624.48 | 4,868 | BDD19F8 |
0.27% | IMVT | IMMUNOVANT INC | -- | $262,394.70 | 9,017 | BJRFSB7 |
0.26% | AXSM | AXSOME THERAPEUTICS INC | -- | $253,705.96 | 2,932 | BYZR4X4 |
0.25% | GH | GUARDANT HEALTH INC | -- | $249,282.00 | 7,554 | BFXC911 |
0.24% | IBRX | IMMUNITYBIO INC | -- | $239,513.34 | 42,694 | BNSP0B8 |
0.23% | RARE | ULTRAGENYX PHARMACEUTICAL IN | -- | $230,221.52 | 5,132 | BJ62Z18 |
0.22% | MRUS | MERUS NV | -- | $221,582.91 | 4,089 | BZBY005 |
0.22% | ARWR | ARROWHEAD PHARMACEUTICALS IN | -- | $216,160.92 | 7,668 | BYQBFJ8 |
0.21% | ACLX | ARCELLX INC | -- | $212,746.23 | 3,303 | BPCJ1Q2 |
0.21% | DNLI | DENALI THERAPEUTICS INC | -- | $212,176.40 | 8,804 | BD2B4V0 |
0.21% | TWST | TWIST BIOSCIENCE CORP | -- | $208,797.60 | 3,595 | BGKG6G7 |
0.21% | XENE | XENON PHARMACEUTICALS INC | -- | $204,853.60 | 4,660 | BRJ3GY4 |
0.20% | IDYA | IDEAYA BIOSCIENCES INC | -- | $198,046.08 | 4,672 | BK0VHF6 |
0.20% | ACAD | ACADIA PHARMACEUTICALS INC | -- | $195,208.86 | 10,199 | 2713317 |
0.20% | MORF | MORPHIC HOLDING INC | -- | $193,514.10 | 3,422 | BK8M4J4 |
0.19% | ADMA | ADMA BIOLOGICS INC | -- | $188,319.60 | 14,310 | B9NSBM2 |
0.19% | FOLD | AMICUS THERAPEUTICS INC | -- | $186,151.48 | 18,286 | B19FQ48 |
0.19% | RYTM | RHYTHM PHARMACEUTICALS INC | -- | $184,624.20 | 3,764 | BF2YWG4 |
0.18% | SWTX | SPRINGWORKS THERAPEUTICS INC | -- | $173,994.96 | 4,574 | BGMGM89 |
0.17% | GERN | GERON CORP | -- | $170,630.56 | 36,616 | 2370381 |
0.17% | KYMR | KYMERA THERAPEUTICS INC | -- | $168,717.52 | 3,788 | BMPRZV5 |
0.17% | AGIO | AGIOS PHARMACEUTICALS INC | -- | $168,415.25 | 3,505 | BCBVTX1 |
0.17% | BEAM | BEAM THERAPEUTICS INC | -- | $168,384.34 | 5,081 | BK6L288 |
0.16% | PTCT | PTC THERAPEUTICS INC | -- | $161,416.15 | 4,735 | B17VCN9 |
0.16% | IOVA | IOVANCE BIOTHERAPEUTICS INC | -- | $159,803.00 | 17,276 | BF0DMK7 |
0.16% | NTLA | INTELLIA THERAPEUTICS INC | -- | $157,834.00 | 5,956 | BYZM6C2 |
0.16% | VCEL | VERICEL CORP | -- | $157,012.32 | 3,001 | BSBMN89 |
0.16% | MYGN | MYRIAD GENETICS INC | -- | $154,425.25 | 5,585 | 2614153 |
0.15% | FTRE | FORTREA HOLDINGS INC | -- | $148,571.48 | 5,519 | BRXYZ57 |
0.15% | NVAX | NOVAVAX INC | -- | $148,309.48 | 8,668 | BJDQXG4 |
0.15% | PTGX | PROTAGONIST THERAPEUTICS INC | -- | $145,853.88 | 3,621 | BDCBCD8 |
0.14% | RCKT | ROCKET PHARMACEUTICALS INC | -- | $142,025.31 | 5,607 | BDFKQ07 |
0.14% | JANX | JANUX THERAPEUTICS INC | -- | $140,811.99 | 3,201 | BMFX8Y7 |
0.14% | APGE | APOGEE THERAPEUTICS INC | -- | $138,561.30 | 2,774 | BM9HHL5 |
0.13% | SNDX | SYNDAX PHARMACEUTICALS INC | -- | $128,474.54 | 5,246 | BN7Q7R7 |
0.13% | AMPH | AMPHASTAR PHARMACEUTICALS IN | -- | $128,247.12 | 3,019 | BNFWZS4 |
0.13% | NVCR | NOVOCURE LTD | -- | $126,349.86 | 6,643 | BYSS4X4 |
0.13% | MIRM | MIRUM PHARMACEUTICALS INC | -- | $126,090.30 | 2,910 | BJDX8Y8 |
0.13% | ARVN | ARVINAS INC | -- | $125,271.25 | 4,225 | BDZ30Q0 |
0.13% | VERA | VERA THERAPEUTICS INC | -- | $123,935.90 | 3,377 | BL55460 |
0.12% | AKRO | AKERO THERAPEUTICS INC | -- | $120,044.28 | 4,269 | BK7Y2V9 |
0.12% | HRMY | HARMONY BIOSCIENCES HOLDINGS | -- | $118,923.52 | 3,506 | BKSGZN7 |
0.12% | LGND | LIGAND PHARMACEUTICALS | -- | $118,818.26 | 1,109 | 2501578 |
0.12% | RXRX | RECURSION PHARMACEUTICALS-A | -- | $118,703.60 | 14,216 | BM9FJ13 |
0.12% | GPCR | STRUCTURE THERAPEUTICS INC | -- | $116,838.95 | 3,023 | BQS9486 |
0.12% | KROS | KEROS THERAPEUTICS INC | -- | $116,568.96 | 2,228 | BM7V485 |
0.11% | VCYT | VERACYTE INC | -- | $111,958.40 | 4,720 | BFTWZY0 |
0.11% | EWTX | EDGEWISE THERAPEUTICS INC | -- | $109,438.68 | 5,766 | BKY5JZ8 |
0.11% | SUPN | SUPERNUS PHARMACEUTICALS INC | -- | $104,365.50 | 3,394 | B72ZBG4 |
0.10% | BCRX | BIOCRYST PHARMACEUTICALS INC | -- | $100,009.00 | 12,740 | 2100362 |
0.10% | AVDL | AVADEL PHARMACEUTICALS | -- | $99,216.48 | 5,934 | BDGMC59 |
0.10% | KURA | KURA ONCOLOGY INC | -- | $99,186.27 | 4,703 | BYZD465 |
0.10% | MNKD | MANNKIND CORP | -- | $98,338.50 | 16,810 | BF081J4 |
0.10% | VRNA | VERONA PHARMA PLC - ADR | -- | $97,807.19 | 4,303 | BYWPZK5 |
0.09% | DVAX | DYNAVAX TECHNOLOGIES CORP | -- | $93,820.41 | 8,081 | BRJZSK0 |
0.09% | IMCR | IMMUNOCORE HOLDINGS PLC-ADR | -- | $92,379.26 | 2,302 | BLCD809 |
0.09% | VIR | VIR BIOTECHNOLOGY INC | -- | $89,869.30 | 8,399 | BK4PZ38 |
0.09% | SANA | SANA BIOTECHNOLOGY INC | -- | $87,513.60 | 13,674 | BMFJJ97 |
0.09% | DAWN | DAY ONE BIOPHARMACEUTICALS I | -- | $86,481.85 | 5,395 | BLB0YH0 |
0.08% | XNCR | XENCOR INC | -- | $82,421.55 | 3,807 | BGCYWN8 |
0.08% | ANIP | ANI PHARMACEUTICALS INC | -- | $81,845.50 | 1,294 | BCDWBX6 |
0.08% | PRTA | PROTHENA CORP PLC | -- | $81,205.32 | 3,324 | B91XRN2 |
0.08% | ARDX | ARDELYX INC | -- | $81,175.28 | 14,444 | BN89V40 |
0.08% | OCUL | OCULAR THERAPEUTIX INC | -- | $80,607.66 | 9,562 | BNZB1X8 |
0.08% | NRIX | NURIX THERAPEUTICS INC | -- | $80,322.34 | 3,661 | BMVLGP2 |
0.08% | ELVN | ENLIVEN THERAPEUTICS INC | -- | $79,308.24 | 2,904 | BMFD115 |
0.08% | MRVI | MARAVAI LIFESCIENCES HLDGS-A | -- | $75,102.84 | 8,199 | BMCWKZ2 |
0.07% | GMAB | GENMAB A/S -SP ADR | -- | $73,447.44 | 2,588 | BBC9WC7 |
0.07% | RLAY | RELAY THERAPEUTICS INC | -- | $73,254.36 | 8,194 | BN2R582 |
0.07% | COLL | COLLEGIUM PHARMACEUTICAL INC | -- | $72,881.60 | 2,020 | BX7RSN3 |
0.07% | ARQT | ARCUTIS BIOTHERAPEUTICS INC | -- | $71,960.22 | 7,146 | BKX9VD3 |
0.07% | CGEM | CULLINAN THERAPEUTICS INC | -- | $71,729.28 | 3,558 | BM90J52 |
0.07% | INVA | INNOVIVA INC | -- | $71,510.25 | 3,855 | BDDXF67 |
0.07% | IRON | DISC MEDICINE INC | -- | $69,692.42 | 1,526 | BMGJZJ8 |
0.07% | IRWD | IRONWOOD PHARMACEUTICALS INC | -- | $69,076.48 | 9,812 | B3MZ6K5 |
0.07% | SPRY | ARS PHARMACEUTICALS INC | -- | $65,682.36 | 5,982 | BMCR7V2 |
0.07% | KNSA | KINIKSA PHARMACEUTICALS INTE | -- | $64,986.56 | 2,488 | BRXB0C0 |
0.06% | TNGX | TANGO THERAPEUTICS INC | -- | $64,301.25 | 6,595 | BP2P6L0 |
0.06% | ANAB | ANAPTYSBIO INC | -- | $62,520.22 | 1,687 | BDRW1L7 |
0.06% | ZLAB | ZAI LAB LTD-ADR | -- | $59,918.22 | 3,177 | BD9GVY0 |
0.06% | ABCL | ABCELLERA BIOLOGICS INC | -- | $59,175.52 | 18,152 | BL53SR3 |
0.06% | FDMT | 4D MOLECULAR THERAPEUTICS IN | -- | $58,573.20 | 3,192 | BKLXFX5 |
0.06% | HUMA | HUMACYTE INC | -- | $58,366.94 | 7,351 | BMYTJP4 |
0.06% | TARS | TARSUS PHARMACEUTICALS INC | -- | $58,323.32 | 2,332 | BMH5RL1 |
0.06% | GRFS | GRIFOLS SA-ADR | -- | $58,289.94 | 7,531 | B8K7T65 |
0.06% | PCRX | PACIRA BIOSCIENCES INC | -- | $57,546.19 | 2,873 | B3X26D8 |
0.06% | AUTL | AUTOLUS THERAPEUTICS PLC | -- | $57,501.71 | 12,313 | BFMLGR4 |
0.06% | COGT | COGENT BIOSCIENCES INC | -- | $56,187.04 | 5,902 | BLR6XK8 |
0.06% | ETNB | 89BIO INC | -- | $56,123.76 | 6,074 | BK1K484 |
0.05% | BCYC | BICYCLE THERAPEUTICS PLC-ADR | -- | $54,363.18 | 2,218 | BKDQKM6 |
0.05% | HROW | HARROW INC | -- | $53,401.40 | 2,185 | BHNDW86 |
0.05% | LXRX | LEXICON PHARMACEUTICALS INC | -- | $53,335.24 | 22,316 | BWFZX59 |
0.05% | OLMA | OLEMA PHARMACEUTICALS INC | -- | $53,264.36 | 3,452 | BMZ4LN0 |
0.05% | ERAS | ERASCA INC | -- | $52,611.20 | 16,040 | BNLYBF3 |
0.05% | CVAC | CUREVAC NV | -- | $51,510.84 | 13,847 | BN4RD42 |
0.05% | AUPH | AURINIA PHARMACEUTICALS INC | -- | $50,148.72 | 8,829 | BFWLC09 |
0.05% | PLRX | PLIANT THERAPEUTICS INC | -- | $49,789.88 | 3,724 | BMDWW66 |
0.05% | ORIC | ORIC PHARMACEUTICALS INC | -- | $49,527.80 | 4,162 | BKVDFF7 |
0.05% | WVE | WAVE LIFE SCIENCES LTD | -- | $49,360.27 | 7,559 | BYZG9R0 |
0.05% | EOLS | EVOLUS INC | -- | $47,578.15 | 3,865 | BDRJH21 |
0.05% | ZYME | ZYMEWORKS INC | -- | $46,923.75 | 4,365 | BPCQZY9 |
0.05% | TVTX | TRAVERE THERAPEUTICS INC | -- | $46,483.00 | 4,700 | BLFGJD5 |
0.05% | SIGA | SIGA TECHNOLOGIES INC | -- | $46,182.80 | 4,390 | 2107437 |
0.05% | SRRK | SCHOLAR ROCK HOLDING CORP | -- | $45,694.72 | 4,924 | BFZQ0L8 |
0.05% | ABUS | ARBUTUS BIOPHARMA CORP | -- | $45,431.10 | 11,649 | BZ0QMB7 |
0.04% | RGNX | REGENXBIO INC | -- | $43,563.20 | 3,040 | BZ0G875 |
0.04% | SLRN | ACELYRIN INC | -- | $42,791.00 | 6,113 | BQPF874 |
0.04% | PHAT | PHATHOM PHARMACEUTICALS INC | -- | $42,416.62 | 3,613 | BJLKVS6 |
0.04% | PRME | PRIME MEDICINE INC | -- | $41,564.49 | 7,409 | BPBJFM7 |
0.04% | MLYS | MINERALYS THERAPEUTICS INC | -- | $41,224.25 | 3,065 | BP9N0G0 |
0.04% | ADPT | ADAPTIVE BIOTECHNOLOGIES | -- | $41,022.96 | 9,096 | BJ5FZ74 |
0.04% | SAGE | SAGE THERAPEUTICS INC | -- | $40,827.85 | 3,715 | BP4GNK9 |
0.04% | ARCT | ARCTURUS THERAPEUTICS HOLDIN | -- | $40,028.41 | 1,663 | BKC9SX3 |
0.04% | PETQ | PETIQ INC | -- | $39,905.47 | 1,823 | BDH65C8 |
0.04% | ITOS | ITEOS THERAPEUTICS INC | -- | $39,583.00 | 2,300 | BMWXFT4 |
0.04% | REPL | REPLIMUNE GROUP INC | -- | $39,236.85 | 3,791 | BDDVW37 |
0.04% | ALLO | ALLOGENE THERAPEUTICS INC | -- | $38,667.00 | 12,889 | BFZNYB7 |
0.04% | ALEC | ALECTOR INC | -- | $38,609.01 | 5,949 | BJ4LDC4 |
0.04% | CNTA | CENTESSA PHARMACEUTICALS-ADR | -- | $38,570.84 | 3,578 | BLB0YQ9 |
0.04% | KALV | KALVISTA PHARMACEUTICALS INC | -- | $38,513.16 | 2,604 | BD06CS0 |
0.04% | VERV | VERVE THERAPEUTICS INC | -- | $38,346.80 | 5,182 | BNKGXX2 |
0.04% | SVRA | SAVARA INC | -- | $38,043.80 | 8,530 | BYXGN81 |
0.04% | URGN | UROGEN PHARMA LTD | -- | $36,476.85 | 2,231 | BZ7PJQ1 |
0.04% | TERN | TERNS PHARMACEUTICALS INC | -- | $35,967.92 | 3,992 | BMDJ0C9 |
0.04% | PACB | PACIFIC BIOSCIENCES OF CALIF | -- | $35,895.76 | 16,813 | B4N8MH9 |
0.04% | CSTL | CASTLE BIOSCIENCES INC | -- | $35,886.24 | 1,704 | BKLCWZ3 |
0.04% | HCM | HUTCHMED CHINA-ADR | -- | $35,542.40 | 1,915 | BYXV9H7 |
0.04% | AVXL | ANAVEX LIFE SCIENCES CORP | -- | $35,209.76 | 5,224 | BYTYP72 |
0.04% | OABI | OMNIAB INC | -- | $35,138.40 | 7,260 | BN13S71 |
0.03% | GLPG | GALAPAGOS NV-SPON ADR | -- | $34,487.40 | 1,255 | B292NQ7 |
0.03% | FULC | FULCRUM THERAPEUTICS INC | -- | $34,063.68 | 3,836 | BJDX8Z9 |
0.03% | YMAB | Y-MABS THERAPEUTICS INC | -- | $33,943.77 | 2,709 | BG31GH0 |
0.03% | THRD | THIRD HARMONIC BIO INC | -- | $31,473.60 | 2,528 | BNNPQY8 |
0.03% | EYPT | EYEPOINT PHARMACEUTICALS INC | -- | $31,227.36 | 3,216 | BMGS7L1 |
0.03% | VYGR | VOYAGER THERAPEUTICS INC | -- | $31,128.66 | 3,358 | BY7RB53 |
0.03% | MXCT | MAXCYTE INC | -- | $30,909.87 | 6,453 | BKMQF66 |
0.03% | TBPH | THERAVANCE BIOPHARMA INC | -- | $30,770.50 | 3,002 | BMNDK09 |
0.03% | EDIT | EDITAS MEDICINE INC | -- | $28,679.40 | 5,076 | BZ8FPH3 |
0.03% | TRML | TOURMALINE BIO INC | -- | $28,414.85 | 1,583 | BQ80NC6 |
0.03% | GRAL | GRAIL INC | -- | $26,748.48 | 1,639 | BSLSSX7 |
0.03% | TSHA | TAYSHA GENE THERAPIES INC | -- | $26,553.50 | 11,545 | BNC1BX1 |
0.03% | PGEN | PRECIGEN INC | -- | $26,177.76 | 15,582 | BKM5C84 |
0.03% | LYEL | LYELL IMMUNOPHARMA INC | -- | $25,808.68 | 15,737 | BN6MB18 |
0.03% | RVNC | REVANCE THERAPEUTICS INC | -- | $25,225.20 | 6,435 | BJFSR99 |
0.03% | QURE | UNIQURE NV | -- | $24,971.66 | 2,996 | BJFSR88 |
0.02% | XERS | XERIS BIOPHARMA HOLDINGS INC | -- | $23,884.11 | 9,151 | BLR7H87 |
0.02% | ACIU | AC IMMUNE SA | -- | $23,807.99 | 6,089 | BZC0D70 |
0.02% | PAHC | PHIBRO ANIMAL HEALTH CORP-A | -- | $23,694.40 | 1,255 | BL95N25 |
0.02% | NAUT | NAUTILUS BIOTECHNOLOGY INC | -- | $22,577.44 | 7,732 | BNG1NK8 |
0.02% | VNDA | VANDA PHARMACEUTICALS INC | -- | $22,198.56 | 3,592 | B12W3P6 |
0.02% | MGNX | MACROGENICS INC | -- | $21,456.30 | 3,866 | BFDV8K0 |
0.02% | CABA | CABALETTA BIO INC | -- | $21,426.20 | 2,980 | BK5MWR1 |
0.02% | AVIR | ATEA PHARMACEUTICALS INC | -- | $20,376.16 | 5,198 | BLN9Z50 |
0.02% | MGTX | MEIRAGTX HOLDINGS PLC | -- | $20,083.14 | 3,969 | BFYQFJ2 |
0.02% | AMRN | AMARIN CORP PLC -ADR | -- | $19,775.31 | 24,834 | 2301938 |
0.02% | ZNTL | ZENTALIS PHARMACEUTICALS INC | -- | $19,592.01 | 4,383 | BMQ5T49 |
0.02% | ALXO | ALX ONCOLOGY HOLDINGS INC | -- | $19,450.75 | 3,215 | BLN7XQ1 |
0.02% | ATAI | ATAI LIFE SCIENCES NV | -- | $16,429.47 | 10,333 | BN6M8F1 |
0.02% | EXAI | EXSCIENTIA PLC | -- | $16,233.51 | 3,023 | BP48134 |
0.01% | BLUE | BLUEBIRD BIO INC | -- | $14,335.00 | 11,750 | BBFL7S1 |
0.01% | CRBU | CARIBOU BIOSCIENCES INC | -- | $13,881.75 | 5,575 | BNYJR68 |
0.01% | VTYX | VENTYX BIOSCIENCES INC | -- | $12,835.45 | 4,351 | BMG99Y1 |
0.01% | BMEA | BIOMEA FUSION INC | -- | $12,265.56 | 2,214 | BNKF6N0 |
0.01% | CHRS | COHERUS BIOSCIENCES INC | -- | $12,181.04 | 7,082 | BRK0149 |
0.01% | ME | 23ANDME HOLDING CO -CLASS A | -- | $8,791.67 | 19,972 | BM9CKX3 |
0.01% | AMLX | AMYLYX PHARMACEUTICALS INC | -- | $8,268.09 | 4,197 | BPCK358 |
0.01% | RAPT | RAPT THERAPEUTICS INC | -- | $7,194.36 | 2,154 | BK5T6R0 |
0.01% | ACRS | ACLARIS THERAPEUTICS INC | -- | $6,113.22 | 4,398 | BYV2W40 |
-- | MRNS | MARINUS PHARMACEUTICALS INC | -- | $4,849.13 | 3,391 | BM8MVZ3 |
-- | OVID | OVID THERAPEUTICS INC | -- | $4,641.74 | 4,379 | BYPFK63 |
-- | RPHM | RENEO PHARMACEUTICALS INC | -- | $3,094.50 | 2,063 | BMHR7T5 |
-- | 2324462D | CARTESIAN THERAPEUTICS-CVR | -- | $1,761.30 | 9,785 | BM9HFX3 |
-- | -- | TREASURY BILL | -- | $14,978,033.40 | 15,000,000 | BRYQ9Y9 |
-- | -- | NET OTHER ASSETS (LIABILITIES) | -- | $20,239,286.22 | 20,239,286 | -- |
Index
as of 6/28/2024
- Total Number of Companies215
- Price/Earnings Ratio--
- Price/Book Ratio4.157
- Dividend Yield ( % )0.88
- Avg. Index Market Capitalization$7.12 billion
About the Index
The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc., including minimum market capitalization and liquidity requirements.
Distributions
For
- 2024
- 2023
- 2022
Ex-Dividend Date | Record Date | Payable Date | Dividend | Long-Term Capital Gain | Short-Term Capital Gain | Return of Capital |
---|